Endocrinology, Diabetes, and Metabolism· Topic 4.2 Thyroid disorders· 4.2.8

Riedel thyroiditis

Riedel (fibrous) thyroiditis is a rare, IgG4-related fibrosclerosing process that replaces the thyroid gland with dense fibrous tissue, producing a fixed, stony-hard, painless goiter with compressive symptoms such as dyspnea, dysphagia, and hoarseness. First-line treatment is a corticosteroid to shrink the fibrotic mass and arrest progression, with tamoxifen or rituximab reserved for refractory disease and surgery limited to airway compromise.

10 min read3 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    A rare fibrosclerosing thyroid disease: Riedel (fibrous) thyroiditis is an infiltrative process that replaces normal thyroid parenchyma and surrounding neck tissue with dense fibrous tissue…

  • Epidemiology

    A rare cause of thyroid disease overall: Riedel thyroiditis is uncommon relative to Hashimoto, painless, postpartum, subacute granulomatous, and acute suppurative thyroiditis.

  • Risk factors

    Female sex: the predominant demographic risk factor.

  • Pathophysiology

    Infiltrative fibrosclerosis progressively destroys the thyroid gland: dense fibrous tissue replaces normal thyroid parenchyma, in contrast to the lymphocytic infiltration of Hashimoto thyroiditis or…

  • Clinical features

    Fixed, firm, painless thyroid mass: the hallmark physical finding, palpably stony-hard and immobile on examination, unlike the soft-to-firm, mobile goiters of other thyroiditis subtypes.

  • Differential diagnosis

    Hashimoto thyroiditis: produces a diffusely enlarged, non-tender, and typically mobile goiter, unlike the stony-hard, fixed mass of Riedel thyroiditis.

  • Diagnosis

    The diagnosis is confirmed, once a fixed thyroid mass is identified, by open biopsy or surgical resection demonstrating fibrous tissue infiltrating the thyroid and surrounding tissue, without giant…

  • Management

    First, start a corticosteroid to decrease mass size and arrest progression: prednisone 40 mg PO once daily, then taper by 5-10 mg every 1-2 weeks over a total of 4-6 weeks as the mass responds, the…

  • Complications

    Airway obstruction: fibrotic encasement of the trachea can progress to compromise the airway, the most feared complication.

  • Prognosis

    Variable, depending on the extent of extracapsular fibrosis at diagnosis: more extensive compressive disease at presentation portends a more complicated course.

  • Prevention

    No specific primary prevention exists, since Riedel thyroiditis arises from an IgG4-related fibrosclerosing process without an identified preventable trigger.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.